2017 Hot topics in cardiometabolism: an interactive update

Cardiometabolic

Diabetes
Hypertension
Thyroid disorder

Regional conference by Excemed

Friday, Jul 14 - Saturday, Jul 15 2017

Bogotà, Colombia

Language

The official language of this live educational conference will be English. Simultaneous translation from English into Spanish will be provided in plenary room.

Registration status

Closed

To register for this event, contact

For registration, accommodation and any logistic inquiry please contact:
Meridiano Congress International
Event management Team Leader: Federica Russetti
T +39 06 88 595 209 - F +39 06 88595 234
federica.russetti@meridiano.it

Registration fee

225.00€

The registration fee is 225€ and includes:

•   Scientific sessions
•   Coffee breaks and luncheons
•   Educational materials
•   Certificate of attendance

Dinners are not included

Target audiences

General practitioners

Cardiologists

endocrinologists and internists managing diabetes and cardiometabolic diseases in the Latin American region.

Files

Final Programme

Introduction

Access learning resources by clicking the Outcomes tab or scroll down to the Scientific Programme.

Participants registered for this conference: complete the pre-event, post-event and follow-up surveys and you will be entered into a draw to win free registration to a major conference in Latin America. Check your email for the survey invitation.

Overview

Diabetes is one of the largest and most alarming health emergencies of the 21st century, affecting over 400 million people worldwide. Managing patients with diabetes and pre-diabetes is a challenge when considering the pathophysiologicaly complex pathways underlying glucose metabolism disorders. Deep knowledge of pharmacological mechanisms allows for effective prevention strategies for diabetes among those with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) and effective management of patients with overt diabetes. Thyroid disorders are among the most prevalent endocrine diseases, with significant impact on quality of life and increased risk of morbidity. Thyroid hormones regulate the homeostasis of various tissues and thyroid diseases should be adequately treated to avoid adverse clinical outcomes. According to the World Health Organization, high blood pressure (hypertension) is the highest risk factor for premature mortality. Worldwide, hypertension causes an estimated 7.5 million deaths per year and is a major risk factor for invalidating or lethal events including ischaemic and haemorrhagic stroke, coronary heart disease, heart failure and renal impairment. Taken together, hypertension and diabetes share common pathophysiologic mechanisms, health outcomes and clinical issues that are often tough tasks to face in clinical practice.

This EXCEMED live educational will address cutting edge research advancements in the areas of cardiometabolic medicine and will discuss the daily clinical approaches to the complex cardiometabolic patient.

Learning objectives

By attending this live educational conference, participants will be able to:

Understand the pathophysiology linking insulin resistance, pre diabetes, diabetes, cardiovascular disease and other disorders
Consciously apply the most recent guidelines to managing diabetes and hypertension
Discuss challenging forms of hypertension and hypertensive-related disease
Identify the most frequent thyroid pathologies
Translate research into clinical practice by discussing clinical cases

Scientific programme

Friday, 14 July 2017

09.15 Welcoming introduction

Session I: Pre-diabetes

Chairs: G. Brenta (Argentina), Guido Grassi (Italy), J.P. Lopez-Jaramillo (Colombia)

09.30 L1 pre-diabetes: all start during childhood. Social causes and pathophysiology
    J.P. Lopez-Jaramillo (Colombia)

09.45    Q&A

10.05 L2 pre-diabetes: stopping the path towards diabetes and cardiovascular diseases
    Osama Hamdy (USA)

10.20    Q&A

10.40    Coffee break

Session II: Metformin: 60 years of an evergreen molecule

Chairs: G. Brenta (Argentina), Guido Grassi (Italy), J.P. Lopez-Jaramillo (Colombia)

11.00 L3 metformin: mechanism of action and cardiovascular benefits
    J. Castillo Barcias (Colombia)

11.15    Q&A

11.35 L4 metformin beyond diabetes: future perspectives of an old molecule (pcOS, obesity, etc.)
    Nicola Napoli (Italy)

11.50    Q&A

12.10    Morning Wrap-up

12.30    Lunch

Session III: Thyroid

Chairs: G. Brenta (Argentina), Guido Grassi (Italy), J.P. Lopez-Jaramillo (Colombia)

13.45 L5 subclinical hypothyroidism: Cardiovascular consequences
    G. Brenta (Argentina)

14.00    Q&A

14.20 L6 medullary thyroid carcinoma
    P.A. Kopp (USA)

14.35    Q&A

14.55    Workshop “Solve & Win” Interactive clinical case solving

Group 1	Group 2
Clinical case 1: thyroid nodule	Clinical case 2: morbid obesity

16.00 Workshop plenary outcome sharing (this sharing session will be graphically recorded)

Group 1	Group 2
16.00-16.30	16.30-17.00

17.00 Concluding remarks

End of the first day

Saturday, 15 July 2017

Session IV: Cardiovascular: The best clinical approach to hypertension and associated diseases

Chairs: G. Brenta (Argentina), Guido Grassi (Italy), J.P. Lopez-Jaramillo (Colombia)

09.30 L7 heart rate as a target in the treatment of hypertensive patients: fact or fancy?
    L. A. Bortolotto (Brazil)

09.45    Q&A

10.05 L8 hypertension and coronary artery disease
    G. Grassi (Italy)

10.25    Q&A

10.45    Coffee break